Clinical Trials Directory

Trials / Completed

CompletedNCT01432522

A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine

Comparison of Absorption of Epinephrine Into the Circulation After Epinephrine Intranasal Spray Administration and After Intramuscular Injection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Siriraj Hospital · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

Detailed description

Patients are reluctant to use Epipen® on emergency basis, perhaps because of improperly training, hesitancy and fear of needle. Other route of administration of epinephrine (EPI) may be more benefit such as intranasal route.

Conditions

Interventions

TypeNameDescription
DRUGEpinephrine1. Intranasal epinephrine 5 mg /spray 2. Intramuscular epinephrine 0.3 mg 3. Intranasal saline spray

Timeline

Start date
2010-07-01
Primary completion
2011-08-01
Completion
2011-09-01
First posted
2011-09-13
Last updated
2011-09-13

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01432522. Inclusion in this directory is not an endorsement.